Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Tong, J. Articles by Kish, S. J. Search for Related Content PubMed Citation Articles by Tong, J. Articles by Kish, S. J. Neurophysiology Amphetamines

Decreased Striatal Dopamine D₁ Receptor- Stimulated Adenylyl Cyclase Activity in Human Methamphetamine Users

OBJECTIVE: It has been assumed that some behavioral changes associated with repeated exposure to dopaminergic psychostimulant drugs might be explained by changes in activity of dopamine receptors, including the dopamine D₁ receptor, which is linked by a stimulatory G protein to the effector enzyme adenylyl cyclase. To establish whether dopamine D₁ receptor function might be altered in human methamphetamine users, the authors measured dopamine-stimulated adenylyl cyclase activity in the brain of chronic human users of the drug. METHOD: Adenylyl cyclase activity stimulated by dopamine and by guanylyl-imidodiphosphate (to assess G protein and adenylyl cyclase coupling) was determined in the postmortem brain tissue of 16 methamphetamine users who had used the drug both recently and chronically (i.e., at least 1 year) as well as 21 matched comparison subjects. RESULTS: A 25%–30% decrease in the maximal extent of dopamine stimulation of adenylyl cyclase activity was seen in the striatum (nucleus accumbens, caudate, and putamen) of the methamphetamine users. No changes were found in basal or guanylyl-imidodiphosphate-stimulated enzyme activity. CONCLUSIONS: These data suggest that dopamine receptor function linked to adenylyl cyclase is partially desensitized in the striatum of human methamphetamine users. Decreased dopamine D₁ receptor function might underlie part of the known (drug withdrawal syndrome) or expected (drug tolerance) consequences of methamphetamine exposure in humans.

This article has been cited by other articles:

				B. T. Hope, D. Nagarkar, S. Leonard, and R. A. Wise Long-Term Upregulation of Protein Kinase A and Adenylate Cyclase Levels in Human Smokers J. Neurosci., February 21, 2007; 27(8): 1964 - 1972. [Abstract] [Full Text] [PDF]

				A. Moszczynska, P. Fitzmaurice, L. Ang, K. S. Kalasinsky, G. A. Schmunk, F. J. Peretti, S. S. Aiken, D. J. Wickham, and S. J. Kish Why is parkinsonism not a feature of human methamphetamine users? Brain, February 1, 2004; 127(2): 363 - 370. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us